- Home
- TRML vs JKS Comparison
TRML vs JKS Comparison
Compare TRML & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- JKS
- Stock Information
- Founded
- TRML 2021
- JKS 2006
- Country
- TRML United States
- JKS China
- Employees
- TRML N/A
- JKS N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- JKS Semiconductors
- Sector
- TRML Health Care
- JKS Technology
- Exchange
- TRML Nasdaq
- JKS Nasdaq
- Market Cap
- TRML 1.2B
- JKS 1.2B
- IPO Year
- TRML N/A
- JKS 2010
- Fundamental
- Price
- TRML $47.97
- JKS $21.07
- Analyst Decision
- TRML Hold
- JKS Sell
- Analyst Count
- TRML 12
- JKS 4
- Target Price
- TRML $47.04
- JKS $28.99
- AVG Volume (30 Days)
- TRML 657.3K
- JKS 558.2K
- Earning Date
- TRML 11-13-2025
- JKS 11-17-2025
- Dividend Yield
- TRML N/A
- JKS 7.13%
- EPS Growth
- TRML N/A
- JKS N/A
- EPS
- TRML N/A
- JKS N/A
- Revenue
- TRML N/A
- JKS $11,445,691,729.00
- Revenue This Year
- TRML N/A
- JKS N/A
- Revenue Next Year
- TRML N/A
- JKS $31.21
- P/E Ratio
- TRML N/A
- JKS N/A
- Revenue Growth
- TRML N/A
- JKS N/A
- 52 Week Low
- TRML $11.56
- JKS $13.42
- 52 Week High
- TRML $48.27
- JKS $29.80
- Technical
- Relative Strength Index (RSI)
- TRML 90.29
- JKS 35.36
- Support Level
- TRML $47.88
- JKS $20.97
- Resistance Level
- TRML $48.00
- JKS $23.72
- Average True Range (ATR)
- TRML 0.05
- JKS 1.13
- MACD
- TRML -0.84
- JKS -0.31
- Stochastic Oscillator
- TRML 83.78
- JKS 4.16
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.